Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Needham Sticks to Their Hold Rating for Boston Scientific (BSX)
Boston Scientific's Strong Growth Trajectory Justifies Buy Rating Amid Strategic Advances
Citigroup Adjusts Boston Scientific's Price Target to $98 From $92, Keeps Buy Rating
Jefferies Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $90
Jefferies Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $90
Boston Scientific (BSX) Gets a Buy From Jefferies
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $100
Stifel Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Boston Scientific Is Maintained at Buy by Canaccord Genuity
Critical Insights From Boston Scientific Analyst Ratings: What You Need To Know
Major bank rating | Needham: Downgrades boston scientific rating to "hold" as industry competition intensifies
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $100
Boston Scientific Poised for Strong Performance: Buy Rating Backed by Robust Growth and Key Product Success
Stifel Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $100
Analysts Are Bullish on Top Healthcare Stocks: Alcon (ALC), Boston Scientific (BSX)
Boston Scientific Price Target Maintained With a $86.00/Share by Needham
Boston Scientific Analyst Ratings
Needham Downgrades Boston Scientific(BSX.US) to Hold Rating